COVID-19 vaccination in our transplant recipients: The time is now

We are entering 2021 with an expanding and effective COVID-19 vaccine armamentarium. Recent interim results from COVID-19 vaccine trials, including more than 80,000 participants worldwide, demonstrate remarkable efficacy and low rate of serious adverse events. Based on experience with other vaccines...

Descripción completa

Detalles Bibliográficos
Autores principales: Aslam, Saima, Goldstein, Daniel R., Vos, Robin, Gelman, Andrew E., Kittleson, Michelle M., Wolfe, Cameron, Danziger-Isakov, Lara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Heart and Lung Transplantation. 2021
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834006/
https://www.ncbi.nlm.nih.gov/pubmed/33487534
http://dx.doi.org/10.1016/j.healun.2020.12.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834006/
https://www.ncbi.nlm.nih.gov/pubmed/33487534
http://dx.doi.org/10.1016/j.healun.2020.12.009

Ejemplares similares